Wacker acquires Antibioticos’ fermentation plant in Spain

Wacker acquires Antibioticos’ fermentation plant in Spain

6:56 AM, 21st December 2016
Wacker  logo

MUNICH GERMANY/ LEON, SPAIN: Wacker BioSolutions, the life sciences and biotechnology division of the Wacker Group, is acquiring a large-scale fermentation plant from Antibioticos de Leon SLU (AdL) in Spain.

AdL is an active pharmaceutical ingredient (API) company and largest facility available in Europe for the manufacture of sterile substances derived from penicillin.

The two companies signed a contract of sale. At the Leon plant, Wacker will produce cysteine by fermentation for use in food and pharmaceutical products.

For Wacker, this strategic acquisition is a major step in satisfying globally growing customer demand for cysteine during the years ahead, and in supporting the commercialization of other bioengineered products.

Cysteine is a natural amino acid that is widely used in the pharmaceutical, cosmetics and food sectors not only to produce flavourings but also as a processing auxiliary for breaking down gluten for bakery goods, as a radical scavenger in cosmetics and as an expectorant in cough medicines.

Through the acquisition, it will obtain a production line with a fermentation capacity of 800 m3 from AdL. The Munich-based chemical company intends to invest a total of about €30 million in modernising the existing facility. And adding a production equipment over the next few years, thereby creating some 35 new jobs at the site. The transaction is expected to close by year-end.

“The acquisition is a key step in strengthening our position as the global market and technology leader for fermentation-generated cysteine. It gives us an ideal position to securely meet our customers’ growing demand for cysteine and to commercialise new fermenter products in the future,” said Auguste Willems, member of Wacker’s executive board.

“This step is an excellent opportunity to use the spare AdL fermentation capacity, while it underscores the strategy of converting our installation in a cluster of activities with added value. We are happy that the Wacker Group is investing in Leon and are sure we have found the right partner to continue developing this site for a successful future,” added Juan Molins, managing director of AdL.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

FMC unveils new coating solution for nutraceuticals

PHILADELPHIA, US: FMC Corporation's health and nutrition business has unveiled its new Aquateric N100 enteric coating solution, a new alginate-based p ...

Read more
Krishna Antioxidants plans to commission new facility; celebrates 25 years

MUMBAI, INDIA: Krishna Antioxidants Pvt Ltd (KAPL), the leading speciality chemicals manufacturer said it has plans to commission its new facility soo ...

Read more
KBR bags 2 global engineering services contract from BP

HOUSTON, US: KBR Inc has been awarded two global contracts by BP International Limited; one for the provision of conceptual engineering services and a ...

Read more
BioAmber, CJ CheilJedang plan succinic acid JV in Asia

MONTREAL, CANADA: BioAmber Inc has signed a non-binding letter of intent with South Korean-based CJ CheilJedang Corporation (CJCJ). Under th ...

Read more
Berry Plastics appoints new president for consumer packaging unit

EVANSVILLE, US: Berry Plastics Group Inc has appointed Jean-Marc Galvez as president of its consumer packaging division, effective 1 January 2017. Gal ...

Read more
Praxair expands CO2, dry ice supply in Northeastern US

DANBURY, US: Praxair Inc said that it has started up its carbon dioxide (CO2) purification and liquefaction plant at Delaware City Refining Company&rs ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X